期刊文献+

载阿霉素海藻酸钠纳米粒的制备及体外释药行为研究 被引量:2

Preparation of doxorubicin-loading sodium alginate nanoparticles and their in vitro release
下载PDF
导出
摘要 目的以海藻酸钠(sodium alginate,ALG)为材料,制备载阿霉素海藻酸钠纳米粒(doxorubicin loading nanoparticles,DOX-ALG-NPs),并对其载药、释药特性进行研究。方法采用微乳-离子交联法制备空白海藻酸钠纳米粒(ALG-NPs),以吸附法载药制备阿霉素海藻酸钠纳米粒(DOX-ALG-NPs)。采用效应面法对ALG-NPs的处方进行优化,并考察ALG-NPs悬液浓度、药载比、孵育时间及孵育温度对ALG-NPs载药性能的影响。对DOX-ALG-NPs的基本性质及体外释药行为进行考察。结果成功制备了粒径为(262.0±4.5)nm的ALG-NPs及粒径为(159.8±8.1)nm、包封率及载药量分别为(94.2±0.5)%和(19.05±0.085)%的DOX-ALG-NPs。与原料药DOX相比,DOX-ALG-NPs在生理盐水与PBS(pH=7.4)中均呈现明显的缓释作用,在生理盐水和PBS中2 h与5 h时分别释放药物(38.1±1.5)%与(55.5±1.1)%、(40.0±1.8)%与(48.1±2.5)%,24 h时分别释放(73.1±3.2)%、(60.3±3.4)%。结论所制备的DOX-ALG-NPs形态圆整,粒径小且分布均匀,包封率及载药量较高,具有缓释性能,有望用作抗癌药物传递系统。 Objective To prepare doxorubicin-loading sodium alginate nanoparticles (DOX-ALG-NPs) with sodium alginate as the carrier material and to investigate the drug loading capacity and release behavior in vitro. Methods Blank ALG-NPs were prepared by microemulsion-ionotropic gelation method, and DOX was loaded by adsorption. Response surface method was used to optimize the formulation of ALG-NPs. The influence of ALG-NP concentration, ratio of DOX to ALG, incubation time and incubation temperature on drug loading capacity of ALG-NPs was determined. The basic properties and drug release behaviors in vitro were characterized. Results The optimized ALG-NPs and DOX-ALG-NPs were round with a mean size of (262.0 ±4.5) nm and (159.8±8.1) nm, respectively. The entrapment efficiency and drug loading rate of DOX-ALG-NPs were (94.2±0.5)% and (19.05 ±0.085) %, respectively. Compared with DOX, the release behaviors of DOX-ALG-NPs in both normal saline and PBS (pH = 7. 4) demonstrated typical sustained release. In the normal saline the accumulative drug release percentage (Q%) at 2 h and 5 h was (38.1 ±1.5) % and (55.5 ±1.1) %, while in the PBS was (40.0±1.8) % and (48.1± 2.5) %. At 24 h, the Q% was (73.1± 3.2) % and (60.3 ±3.4) % in the normal saline and the PBS, respectively. Conclusion The optimized DOX-ALG-NPs are round particles with small size and narrow distribution. The DOX-ALG-NPs have high entrapment efficiency, drug loading rate and sustained release as well, which can be used in an anti-cancer drug delivery system.
出处 《中南药学》 CAS 2014年第5期451-456,共6页 Central South Pharmacy
基金 广州市科技攻关计划(No.11C32070756)
关键词 海藻酸钠纳米粒 阿霉素 处方优化 载药 释药 sodium alginate nanopaticle doxorubicin formulation optimization drug loading drug release
  • 相关文献

参考文献13

  • 1Wain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials [J]. Cancer, 2003, 97 (11) : 2869-2879.
  • 2Octavia Y, Tocchetti CG, Gabrielson KL, et al. Doxorubi- cin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies [J]. J Mol Cell Cardiol, 2012, 52 ( 6 ) : 1213-1225.
  • 3Sundar S, Kundu J, Kundu SC. Biopolymeric nanoparticles [J]. SciTechnolAdvMat, 2010, 11 ( 1 ) : 14104-14116.
  • 4Steichen SD, Caldorera-Moore M, Peppas NA. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics [J]. Eur J Pharm Sci, 2013, 48 ( 3 ) : 416 -427.
  • 5Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs [J].AnnuRevMed, 2012, 63 ( 1 ) : 185-198.
  • 6陈蕾,罗志刚,何小维.海藻酸钠在医学工程上的应用研究进展[J].医疗卫生装备,2008,29(9):33-35. 被引量:16
  • 7仲静洁,王东凯,张翠霞,高红,张勖.海藻酸钠在药物制剂中的研究进展[J].中国新药杂志,2007,16(8):591-594. 被引量:27
  • 8Reis CP, Neufeld RJ, Vilela S, et al. Review and current sta- tus of emulsion/dispersion technology using an internal gelation process for the design of alginate particles [J]. J Microencapsu-lation, 2006, 23 (3) : 245-257.
  • 9秦明娜,葛忠学,郑晓东.微乳法制备纳米材料的研究进展[J].化工时刊,2008,22(7):50-53. 被引量:7
  • 10Machado AHE, Lundberg D, Ribeiro A J, et al. Preparation of calcium alginate nanoparticles using water-in-oil ( W/O ) nanoemulsions [J]. Langmuir: the ACS Journal of Surfaces and Colloids, 2012, 28 (9) : 4131-4141.

二级参考文献71

共引文献47

同被引文献56

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部